Scoopfeeds — Intelligent news, curated.
Deutsche Bank cuts Bio-Techne stock rating on Merck acquisition
business

Deutsche Bank cuts Bio-Techne stock rating on Merck acquisition

Investing.com · Jun 26, 2026, 8:21 AM

Deutsche Bank cuts Bio-Techne stock rating on Merck acquisition

Read full story on Investing.com → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop